{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-025706","form_type":"8-K","ticker":"ASPN","cik":"0001145986","company_name":"ASPEN AEROGELS INC","filed_at":"2023-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.065705+00:00","generated_at":"2026-06-14T09:00:03.623937+00:00","sec_items":["5.02","5.07","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspen Aerogels shareholders approve doubling of authorized shares to 250M and 2023 equity plan","bullets":["Shareholders approved amendment increasing authorized common shares from 125M to 250M (48.8M for, 13.3M against).","Approved the 2023 Equity Incentive Plan authorizing 3M new shares plus rollover from prior plan (35.1M for, 9.2M against).","Approved officer exculpation amendment under new Delaware law (40.8M for, 4.5M against).","Directors Steven R. Mitchell and Donald R. Young reelected as Class III directors until 2026 annual meeting.","Director Richard F. Reilly's term ended at the annual meeting; no replacement named."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-025706","json":"https://secwatch.observer/filing/0000950170-23-025706.json","markdown":"https://secwatch.observer/filing/0000950170-23-025706.md","text":"https://secwatch.observer/filing/0000950170-23-025706.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1145986/000095017023025706/0000950170-23-025706-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1145986/000095017023025706/aspn-20230601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T09:00:03.623937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"463bf6f3c28916a8be1db3d6d5eee3176a902507","claim":"ASPEN AEROGELS INC: Stockholders approved amendments to the Certificate of Incorporation to add officer exculpation provisions under new Delaware law and to increase authorized common shares from 125,000,000 to 250,000,000 (effective 2023-06-01).","evidence_excerpt":"The Amendments became effective upon the Company’s filing of a Certificate of Amendment to the Certificate of Incorporation with the Secretary of State of Delaware on June 1, 2023 (the “Certificate of Amendment”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1145986/000095017023025706/0000950170-23-025706-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-06-01"}],"fact_type":"governance_change"},{"claim_id":"2e071325fe80aebef73c76630baefb760a3a2d7b","claim":"ASPEN AEROGELS INC shareholders approved Approval of the Aspen Aerogels 2023 Equity Incentive Plan at the 2023-06-01 meeting.","evidence_excerpt":"the Company’s stockholders approved the adoption of the Aspen Aerogels 2023 Equity Incentive Plan","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1145986/000095017023025706/0000950170-23-025706-index.htm","confidence":0.7,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}